About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 561 record(s)
Req # A-2019-001801
Adverse Reaction Report (AER). Report numbers: E2B_02474051, E2B_02476773, E2B_02492835, E2B_02492851, E2B_02494029, E2B_02494048.Organization: Health Canada
May 2020
Req # A-2019-001813
Adverse Reaction Report (AER). Report number: E2B_02864961.Organization: Health Canada
May 2020
Req # A-2019-001825
Adverse Reaction Report (AER). Report number: E2B_02706714.Organization: Health Canada
May 2020
Req # A-2019-001873
Adverse Reaction Report (AER). Report number: E2B_02771953.Organization: Health Canada
May 2020
Req # A-2019-001881
Adverse Reaction Report (AER). Report number: E2B_02786489.Organization: Health Canada
May 2020
Req # A-2019-001882
Adverse Reaction Report (AER). Report number: E2B_02786481.Organization: Health Canada
May 2020
Req # A-2019-002000
Adverse Reaction Report (AER). Report number: E2B_000710494.Organization: Health Canada
May 2020
Req # A-2019-001906
Adverse Reaction Report (AER) for LEFLUNOMIDE. Report numbers: E2B_02372682, E2B_02384536, E2B_02359715, E2B_02390532, E2B_02393822, E2B_02394447, E2B_02396860, E2B_02411125, E2B_02382803, E2B_02378301, E2B_02400629, E2B_02396873, E2B_02382937, E2B_02394351, E2B_02386784, E2B_02394072, E2B_02386810, E2B_02378511, E2B_02399503.Organization: Health Canada
May 2020
Req # A-2019-001909
Adverse Reaction Report (AER). Report number: E2B_02764909.Organization: Health Canada
May 2020
Req # A-2019-001910
Adverse Reaction Report (AER). Report number: E2B_02764913.Organization: Health Canada
May 2020